C4 Therapeutics Eulerpool Novinky

C4 Therapeutics Novinky o akciách

C4 Therapeutics sledujú mnohí novinári a investori po celom svete. Najaktuálnejšie správy C4 Therapeutics zhromažďujeme práve tu.

• 8. januára ·

  Yahoo
  C4 Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
• 30. decembra ·

  Yahoo
  Why C4 Therapeutics (CCCC) Is One of the Best Biotech Penny Stocks to Invest in Now?
• 8. decembra ·

  Yahoo
  C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader
• 20. novembra ·

  Yahoo
  C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors
• 6. novembra ·

  SeekingAlpha
  C4 Therapeutics: Holding Fast To A Generous Valuation Heading Into An Important ASH Readout
• 6. novembra ·

  Yahoo
  C4 Therapeutics Announces First Patient Dosed in CFT8919 Clinical Trial
• 5. novembra ·

  Yahoo
  C4 Therapeutics to Present Data from the Ongoing Phase 1/2 Trial of Cemsidomide in Multiple Myeloma and Non-Hodgkin’s Lymphoma at the American Society of Hematology (ASH) Annual Meeting
• 1. novembra ·

  Yahoo
  C4 Therapeutics Third Quarter 2024 Earnings: Beats Expectations
• 1. novembra ·

  TipRanks
  Analysts’ Top Healthcare Picks: C4 Therapeutics (CCCC), Alnylam Pharma (ALNY)
• 31. októbra ·

  TipRanks
  C4 Therapeutics Advances in Protein Degradation Therapy